recombinant human acid ceramidase (Enzyvant Sciences)

N/A

Report date: 2025/03/20 09:12:25

Base Information

Drug Namerecombinant human acid ceramidase (Enzyvant Sciences)
Drug Alias Namerecombinant human acid ceramidase (Plexcera)Plexcerase
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionAcid ceramidase stimulants
TargetsAcid ceramidase
Therapy Area/IndicationsLipid Metabolism Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEurope
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIcahn School Of Medicine At Mount Sinai
China Registration ClassN/A

Develop Information

Active CompaniesEnzyvant Therapeutics Gmbh
Inactive CompaniesPlexcera Therapeutics LLC
Active IndicationsLipid Metabolism Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A